If you need more lookups,
subscriptions start at $34 USD/month.
John Dominy Location
Boston, MA, US
John Dominy Work
Senior Director @ New Company (April 2026 - Present)
Associate Director @ (September 2024 - Present)
Senior Investigator I @ (September 2019 - September 2024)
Investigator III @ (May 2017 - September 2019)
Investigator II @ (July 2013 - March 2017)
Postdoctoral Fellow @ (May 2008 - June 2013)
Graduate student @ Cornell University (January 2003 - January 2008)
Researcher @ University of Florida (January 2002 - January 2003)
John Dominy Education
Cornell University
Doctor of Philosophy (Ph.D.) (Nutritional Biochemistry)
2003-2008
University of Florida
BS (Neurobiology and Neurosciences)
1998-2002
Dana Farber Cancer Institute
Fort Myers High School
John Dominy Skills
Adenoviral production
Animal Models
Biochemistry
Biophysics
CLAMS
Calorimetry
Cell Biology
Cell Culture
Enzyme Assays
Fluorescence
Fluorescence Microscopy
Genetics
Grant Writing
High Throughput Screening
Immunofluorescence
Immunohistochemistry
Immunoprecipitation
In Vivo
Lentiviral production
Life Sciences
Metabolomics
Microscopy
Molecular Biology
Molecular Cloning
Mouse husbandry
Polymerase Chain Reaction (PCR)
Protein Expression
Protein Purification
Textbook writing
Tissue Culture
Transfection
Western Blotting
alphaLISA technology
Gene Expression
Polymerase Chain Reaction Pcr
Gene Delivery
Analytical Skill
Mass Spectrometry
Research
Analysis
Polymerase Chain Reaction
John Dominy Summary
John Dominy, based in Boston, MA, US, is currently a Senior Director at New Company. John Dominy brings experience from previous roles at Novartis and Novartis Institutes for BioMedical Research (NIBR). John Dominy holds a 2003 - 2008 Doctor of Philosophy (Ph.D.) in Nutritional Biochemistry @ Cornell University. With a robust skill set that includes Adenoviral production, Animal Models, Biochemistry, Biophysics, CLAMS and more. John Dominy has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different John Dominy?
Find contact details for 700 million professionals.